ViruCure Therapeutics Company Profile, Contacts & Intelligence

BiotechnologyBnei Brak, Tel-aviv, Il6 employeesFounded 2016
Employees
6
Company source estimate

ViruCure Therapeutics Overview

ViruCure Therapeutics is a biotech company that is developing an oncolytic-virus-based technology platform, using proprietary strains of Newcastle Disease Virus (NDV), for the targeted treatment of a wide range of cancers. INITIAL TARGETED THERAPIES FOR THE TREATMENT OF GBM & LUNG CANCER ViruCure’s robust NADAV platform has already shown the potential to have significant oncolytic effect on a wide range of cancers including Glioblastoma Multiforme (GBM) and lung cancer, which are the two initial target indications to be addressed by ViruCure. DRAMATIC RESULTS IN PROOF OF CONCEPT TRIAL In a Phase 1/2 clinical trial on terminal GBM patients, four of twelve patients responded to treatment and one went into complete remission! Studies have also been conducted on metastatic chemo-resistant melanoma in mice and human organ cultures in lung cancer, head and neck, as well as colorectal carcinomas. THE NADAV TECHNOLOGY PLATFORM NADAV’s oncolytic effect appears to be a result of both direct destruction of the tumor cells (cell death) and activation of a general anti-tumor immune response. This powerful amplification effect is achieved with very low toxicity because NADAV specifically destroys tumor cells and does not attack normal tissues. Furthermore, since NDV is an avian virus, it has not exhibited any pathological effects or severe illnesses in humans in over forty years of research. BREAKTHROUGH TREATMENTS ViruCure believes that NADAV may serve as a breakthrough treatment modality where conventional cancer therapies have shown poor results. Given its broad applicability, the NADAV platform will generate an evergreen pipeline of anti-cancer candidates, some of which ViruCure will bring to market on its own and others through strategic partnerships.

Headquarters
Bnei Brak, Tel-aviv, Il
Industry
Biotechnology
Founded
2016
Company Email
Available in AeroLeads

ViruCure Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Compare Similar Companies to ViruCure Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Eitan Medical Medical Equipment Manufacturing 285 View company
NeuroKaire (formerly Genetika+) Biotechnology Research 45 View company
Centarix Biotechnology Research 43 View company
NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) Biotechnology Research 24 View company
Entera Bio Ltd. Biotechnology Research 20 View company
SENSEERA Biotechnology Research 19 View company
InnoCan Pharma Pharmaceutical Manufacturing 15 View company
IR-Med Inc. (OTCQB:IRME) Medical Equipment Manufacturing 11 View company
Centa Longevity Home Health Care Services 1 View company
RondinX Pharmaceutical Manufacturing Not listed View company